课题基金 / 基金详情

Project 2: STAT3 as a trigger for T1D

Project 2: STAT3 as a trigger for T1D
项目 2:STAT3 作为 T1D 的触发因素
批准号:
10328102
负责人:
Mark S Anderson
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-17 至 2027-01-31

项目摘要

项目成果

Mark S Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Monogenic diseases that have a close association with the development of type 1 diabetes have been informative for unraveling critical pathways that keep this disease in check. Examples of success using this approach include the study of AIRE and FOXP3 which have been informative for identifying pathways in the thymus and T regulatory cells that keep type 1 diabetes in check. Here, we will leverage the recent knowledge that gain of function mutations (GOF) in STAT3 are tightly associated with the development of type 1 diabetes by developing a robust animal model of the syndrome. Our specific aims are: Aim 1: Model the effects of STAT3 GOF in a novel mouse model of autoimmune diabetes (NOD.STAT3K392R/+) Aim 2: Identify and characterize key immune cell populations that are defective in the NOD.STAT3K392R/+ model and in patients with similar STAT3 GOF mutations Aim 3: Identify how central tolerance is potentially altered in STAT3 GOF models These studies will be performed in close collaboration with PPG projects 1 (Cooper) and 3 (Marson) and will help improve our understanding of how the immune tolerance is controlled by STAT3 and how alterations in this molecule can provoke type 1 daibetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Project 2: STAT3 as a trigger for T1D
STAT3 variants as a rheostat of immune tolerance
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
海外基金